KOELIS announces the first interim results of the VIOLETTE trial which evaluates the use of OBT-Fusion® technology in focal ablation of the prostate by microwave needles GRENOBLE, France, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Koelis, SAS (“Koelis” or the “Company”, www.koelis.com), a global leader and innovator in prostate care, announced today passing an important...

Koelis Announces New Compact 3D Probe to Improve Workflow and Reprocessing Koelis is pleased to announce the introduction of our new 3D ultrasound probe that maximizes auto reprocessing compatibility.

Koelis Announces New Product Release at AUA 2024 to Offer Innovative AI-Enhanced MRI Fusion Biopsy Workflow GRENOBLE, France and PRINCETON, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Koelis, SAS (“Koelis” or the “Company”, www.koelis.com), a leader and innovator in prostate care, announced today the release...

KOELIS Announces Partnership with GMP, Providing VA Hospitals with Access to Advanced Prostate Care Technology PRINCETON, N.J., July 29, 2020 (GLOBE NEWSWIRE) -- KOELIS, Inc. today announced final approval by the Department of Veterans Affairs (VA) for providing a pathway for Prostate MRI Fusion for...